Spectral Analysis Probe to Identify Glioblastoma Cells
NCT03293888 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2019-01-25
Summary
This is a pilot, observational study to evaluate the intraoperative sensitivity of the Chaos Wand in detecting tumor tissue with glioblastoma disease.
Conditions
Sponsors & Collaborators
-
University of Oklahoma
lead OTHER
Principal Investigators
-
Michael Sughrue, MD · University of Oklahoma
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-31
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
Countries
- United States
Study Locations
More Related Trials
-
68Ga-citrate PET/MR Imaging for Glioma
NCT03335280 ·Status: TERMINATED
-
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
NCT02590497 ·Status: WITHDRAWN ·Phase: NA
-
Bioenergetic Profiling and Cognition in GBM Patients
NCT03939858 ·Status: TERMINATED
-
Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
NCT05171127 ·Status: COMPLETED
-
Evaluating Tumor Pseudoprogression With FLT-PET and MRI
NCT01105988 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
NCT03287063 ·Status: TERMINATED
-
Investigational Imaging Technique During Brain Surgery
NCT05513859 ·Status: SUSPENDED ·Phase: NA
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
NCT02855086 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
NCT02473484 ·Status: COMPLETED
-
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
NCT00592709 ·Status: COMPLETED
-
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
NCT05281731 ·Status: RECRUITING ·Phase: NA
-
Personalized Trial in ctDNA-level-relapse Glioblastoma
NCT05539339 ·Status: UNKNOWN ·Phase: NA
-
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
NCT05896449 ·Status: COMPLETED ·Phase: NA
-
Establishment of a Brain and Spinal Tumor Tissue Bank
NCT00686387 ·Status: UNKNOWN
-
Utility of PET-MRI in Surveillance of Paediatric Brain Tumours
NCT05553899 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Distant Healing in Glioblastoma Treatment
NCT00029783 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
NCT04545177 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Artificial Intelligence Neuropathologist
NCT05300113 ·Status: UNKNOWN
-
18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
NCT04588454 ·Status: UNKNOWN ·Phase: NA
-
Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach
NCT05420727 ·Status: COMPLETED ·Phase: PHASE1
-
Surgical Resection of Latent Brain Tumors Prior to Recurrence
NCT04810871 ·Status: SUSPENDED ·Phase: NA
-
Confocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma Tumours
NCT02491827 ·Status: TERMINATED
-
Tumor Electric Fields Treatment System for Glioblastoma
NCT04417933 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Evaluation of 3D Ultrasound in Brain Tumor Surgery
NCT05956977 ·Status: UNKNOWN ·Phase: NA